Gallen Christopher C.
EVP Research & Development
Avg. Two Year Performance
No Purchase Track Record
No Sale Track Record
Holdings: 1.84M shares
Last Three Months: 17-Mar-24 -- 16-Jun-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
17-Jun-22 -- 16-Jun-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions